EUVIMEDObjevte EUVIMED
KohortenstudieOpen access · CC BY 4.0

Suicide in people prescribed opioid‐agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study

Rosalyn Fraser iD, Alan Yeung iD, Megan Glancy, Matthew Hickman iD, Hayley E Jones iD, Saket Priyadarshi, Kirsten Horsburgh, Sharon J Hutchinson, Andrew McAuley iD

Addiction · 2025

DOI: 10.1111/add.16680 ↗

At a glance

Kohortenstudie in Addiction, 2025. Written by Rosalyn Fraser and 8 co-authors. Institution: School of Health and Life Sciences, Research Centre for Health (ReacH), Glasgow Caledonian University, Cowcaddens Road, Glasgow, UK. Major MEDLINE topics: Suicide, Opioid-Related Disorders, Analgesics, Opioid. Cited 1 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY 4.0). Funded by: Scottish Government Drug Death Task Force, NIHR, Programme Grants for Applied Research Programme.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and aims Opioid dependence is associated with an increased risk of suicide. Drug‐related mortality among people with opioid dependence in Scotland has more than tripled since 2010; less is known about changes in suicide risk. We aimed to determine if opioid agonist therapy (OAT) in Scotland is protective against suicide and to measure trends in suicide rates in those with opioid dependence over time.

Design

Retrospective cohort study.

Setting

Scotland, UK.

Participants

46 453 individuals in Scotland who received at least one prescription for OAT between 2011 and 2020 with over 304 000 person‐years (pys) of follow‐up.

Measurements

We calculated standardised mortality ratios (SMR) using the age‐ and sex‐specific suicide rates in Scotland for years 2011–2020. We fitted multivariable competing‐risk regression models to estimate suicide rates by OAT exposure and to estimate trends over time, adjusting for potential confounders.

Findings

There were 575 deaths classed as suicide among the cohort and the overall suicide rate was 1.89 (95% confidence interval [CI] = 1.74–2.05) per 1000 pys. Age and sex SMR for suicide was 7.05 times (95% CI = 6.50–7.65) higher than in the general population. After adjustment, OAT was shown to be highly protective against suicide, with rates more than three times greater (adjusted hazard ratio: 3.07; 95% CI = 2.60–3.62) off OAT compared with on OAT. Suicide rates decreased over time, falling from 2.57 (95% CI = 2.19–3.02) per 1000 pys in 2011–12 to 1.48 (95% CI = 1.21–1.82) in 2019–20.

Conclusion

People with opioid dependence in Scotland appear to have a greater risk of suicide than the general population. Treatment is protective, with rates of suicide lower among those on opioid agonist therapy. Suicide rates have decreased over time, during a period in which drug‐related death rates in Scotland have risen to globally high levels.

Subjects

MeSH terms (MEDLINE)

SuicideOpioid-Related DisordersAnalgesics, OpioidHumansScotlandMaleFemaleRetrospective StudiesAdultMiddle AgedYoung AdultOpiate Substitution TreatmentAdolescentCohort StudiesAged

Author keywords

Scotlanddemographyepidemiologyinjectingmodellingopiatesopioid agonist treatmentsuicide

Substances

Analgesics, Opioid

Authors and institutions

  • School of Health and Life Sciences, Research Centre for Health (ReacH), Glasgow Caledonian University, Cowcaddens Road, Glasgow, UK.
  • Public Health Scotland, Gyle Square, South Gyle Crescent, Edinburgh, UK.
  • Bristol Medical School, University of Bristol, Tyndall Avenue, Bristol, UK.
  • Glasgow Alcohol and Drug Recovery Services, Glasgow, UK.
  • Scottish Drugs Forum, Glasgow, UK.

ORCID profiles: Rosalyn Fraser, Alan Yeung, Matthew Hickman, Hayley E Jones, Andrew McAuley

Funding

  • Scottish Government Drug Death Task Force
  • NIHR
  • Programme Grants for Applied Research Programme
  • HPRU BSE
  • NIDA NIH HHS
  • PHS

Cite

APA

Fraser, R., Yeung, A., Glancy, M., Hickman, M., Jones, H. E., Priyadarshi, S., Horsburgh, K., Hutchinson, S. J., & McAuley, A. (2025). Suicide in people prescribed opioid‐agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study. Addiction. https://doi.org/10.1111/add.16680

Vancouver

Fraser R, Yeung A, Glancy M, Hickman M, Jones HE, Priyadarshi S, et al. Suicide in people prescribed opioid‐agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study. Addiction. 2025. doi:10.1111/add.16680

BibTeX
@article{Fraser2025,
  author = {Fraser, Rosalyn and Yeung, Alan and Glancy, Megan and Hickman, Matthew and Jones, Hayley E and Priyadarshi, Saket and Horsburgh, Kirsten and Hutchinson, Sharon J and McAuley, Andrew},
  title = {Suicide in people prescribed opioid‐agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study},
  journal = {Addiction},
  year = {2025},
  doi = {10.1111/add.16680}
}
Start for free →